Infantile Fibrosarcoma and Other Spindle Cell Neoplasms of Infancy. A Review of Morphologically Overlapping yet Molecularly Distinctive Entities

References

• Coffin CM, Alaggio R. Fibroblastic and myofibroblastic tumors in children and adolescents. Pediatr Dev Pathol. 2012;15(1 Suppl):127–80. doi:10.2350/10-12-0944-PB.1.
   PubMedGoogle Scholar
• Davis JL, Rudzinski ER. Pediatric and infantile fibroblastic/myofibroblastic tumors in the molecular era. Surg Pathol Clin. 2020;13(4):739–62. doi:10.1016/j.path.2020.08.009.
   PubMedGoogle Scholar
• Bourgeois JM, Knezevich SR, Mathers JA, Sorensen PH. Molecular detection of the etv6-ntrk3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors. Am J Surg Pathol. 2000;24(7):937–46.
   PubMed Web of Science ®Google Scholar
• Gadd S, Beezhold P, Jennings L, George D, Leuer K, Huang C-C, Huff V, Tognon C, Sorensen PHB, Triche T, et al. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a children’s oncology group study. J Pathol. 2012;228(1):119–30. doi:10.1002/path.4010.
   PubMed Web of Science ®Google Scholar
• Ji Y, Chen S, Yang K, Xia C, Li L. Kaposiform hemangioendothelioma: current knowledge and future perspectives. Orphanet J Rare Dis. 2020;15(1):39. doi:10.1186/s13023-020-1320-1.
   PubMed Web of Science ®Google Scholar
• Hu Z, Chou PM, Jennings LJ, Arva NC. Infantile fibrosarcoma-a clinical and histologic mimicker of vascular malformations: case report and review of the literature. Pediatr Dev Pathol. 2013;16(5):357–63. doi:10.2350/13-05-1335-CR.1.
   PubMed Web of Science ®Google Scholar
• DuBois SG, Laetsch TW, Federman N, Turpin BK, Albert CM, Nagasubramanian R, Anderson ME, Davis JL, Qamoos HE, Reynolds ME, et al. The use of neoadjuvant larotrectinib in the management of children with locally advanced trk fusion sarcomas. Cancer. 2018;124(21):4241–7. doi:10.1002/cncr.31701.
   PubMed Web of Science ®Google Scholar
• Suurmeijer AJ, Dickson BC, Swanson D, Zhang L, Sung Y-S, Huang H-Y, Fletcher CD, Antonescu CR. The histologic spectrum of soft tissue spindle cell tumors with ntrk3 gene rearrangements. Genes Chromosomes Cancer. 2019;58(11):739–46. doi:10.1002/gcc.22767.
   PubMed Web of Science ®Google Scholar
• Antonescu CR. Emerging soft tissue tumors with kinase fusions: an overview of the recent literature with an emphasis on diagnostic criteria. Genes Chromosomes Cancer. 2020;59(8):437–44. doi:10.1002/gcc.22846.
   PubMed Web of Science ®Google Scholar
• Atiq MA, Davis JL, Hornick JL, Dickson BC, Fletcher CDM, Fletcher JA, Folpe AL, Mariño-Enríquez A. Mesenchymal tumors of the gastrointestinal tract with ntrk rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST). Mod Pathol. 2021;34(1):95–103. doi:10.1038/s41379-020-0623-z.
   PubMed Web of Science ®Google Scholar
• Oudijk L, den Bakker MA, Hop WCJ, Cohen M, Charles AK, Alaggio R, Coffin CM, de Krijger RR. Solitary, multifocal and generalized myofibromas: clinicopathological and immunohistochemical features of 114 cases. Histopathology. 2012;60(6B):E1–11. doi:10.1111/j.1365-2559.2012.04221.x.
   PubMed Web of Science ®Google Scholar
• Friedman BJ, Shah KN, Taylor JA, Rubin AI. Congenital myofibroma masquerading as an ulcerated infantile hemangioma in a neonate. Pediatr Dermatol. 2013;30(6):e248–9. doi:10.1111/j.1525-1470.2011.01678.x.
   PubMed Web of Science ®Google Scholar
• Yozu M, Taghavi K, Ervine E, Morreau P, Watson M. A case of congenital solitary testicular myofibroma associated with an undescended testis. Pathology. 2013;45(5):517–9. doi:10.1097/PAT.0b013e3283639bf6.
   PubMed Web of Science ®Google Scholar
• Diplomatico M, Esposito F, Aliberti F, Marzuillo P, Errico ME, Ametrano O. Myofibroma-a common congenital lesion. J Pediatr. 2019;213:245. doi:10.1016/j.jpeds.2019.05.021.
   PubMed Web of Science ®Google Scholar
• Shahzad F, Chappell AG, Purnell CA, Aldulescu M, Chamlin S. Infantile myofibroma presenting as a large ulcerative nodule in a newborn. Case Rep Pediatr. 2019;2019:3476508. doi:10.1155/2019/3476508.
   PubMed Web of Science ®Google Scholar
• Cheung YH, Gayden T, Campeau PM, LeDuc CA, Russo D, Nguyen V-H, Guo J, Qi M, Guan Y, Albrecht S, et al. A recurrent pdgfrb mutation causes familial infantile myofibromatosis. Am J Hum Genet. 2013;92(6):996–1000. doi:10.1016/j.ajhg.2013.04.026.
   PubMed Web of Science ®Google Scholar
• Schrodt BJ, Callen JP. A case of congenital multiple myofibromatosis developing in an infant. Pediatrics. 1999;104(1 Pt 1):113–5. doi:10.1542/peds.104.1.113.
   PubMed Web of Science ®Google Scholar
• Leon-Villapalos J, Wolfe K, Calonje E, Kangesu L. Involuting solitary cutaneous infantile myofibroma and thrombocytopaenia: a previously unreported clinical association. J Plast Reconstr Aesthet Surg. 2007;60(11):1260–2. doi:10.1016/j.bjps.2006.01.019.
   PubMed Web of Science ®Google Scholar
• Bidadi B, Watson A, Weigel B, Oliveira A, Kirkham J, Arndt C. Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: a case report. Pediatr Blood Cancer. 2020;67(6):e28288. doi:10.1002/pbc.28288.
   PubMed Web of Science ®Google Scholar
• Proust S, Benchimol G, Fraitag S, Starck J, Giacobbi V, Pierron G, Bodemer C, Orbach D. Major response to imatinib and chemotherapy in a newborn patient prenatally diagnosed with generalized infantile myofibromatosis. Pediatr Blood Cancer. 2021;68(1):e28576. doi:10.1002/pbc.28576.
   PubMed Web of Science ®Google Scholar
• Saikaly SK, Schoch JJ, Motaparthi K, Shenoy A, Knapik JA, Bender NR. Generalized infantile myofibromatosis with visceral involvement presenting as diffuse hypopigmented macules at birth. Pediatr Dermatol. 2021;38(1):249–52. doi:10.1111/pde.14456.
   PubMed Web of Science ®Google Scholar
• Arts FA, Sciot R, Brichard B, Renard M, de Rocca Serra A, Dachy G, Noël LA, Velghe AI, Galant C, Debiec-Rychter M, et al. Pdgfrb gain-of-function mutations in sporadic infantile myofibromatosis. Hum Mol Genet. 2017;26(10):1801–10. doi:10.1093/hmg/ddx081.
   PubMed Web of Science ®Google Scholar
• Dachy G, de Krijger RR, Fraitag S, Théate I, Brichard B, Hoffman SB, Libbrecht L, Arts FA, Brouillard P, Vikkula M, et al. Association of pdgfrb mutations with pediatric myofibroma and myofibromatosis. JAMA Dermatol. 2019;155(8):946–50. doi:10.1001/jamadermatol.2019.0114.
   PubMed Web of Science ®Google Scholar
• Hassan M, Butler E, Wilson R, Roy A, Zheng Y, Liem P, Rakheja D, Pavlick D, Young LL, Rosenzweig M, et al. Novel pdgfrb rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib. Cold Spring Harb Mol Case Stud. 2019;5(5):a004440. doi:10.1101/mcs.a004440.
   PubMed Web of Science ®Google Scholar
• Guerit E, Arts F, Dachy G, Boulouadnine B, Demoulin JB. Pdgf receptor mutations in human diseases. Cell Mol Life Sci. 2021;78(8):3867–81. doi:10.1007/s00018-020-03753-y.
   PubMed Web of Science ®Google Scholar
• Slack JC, Brundler MA, Nohr E, McIntyre JB, Kurek KC. Molecular alterations in pediatric fibroblastic/myofibroblastic tumors: an appraisal of a next generation sequencing assay in a retrospective single centre study. Pediatr Dev Pathol. 2021;24(5):405–21. doi:10.1177/10935266211015558.
   PubMed Web of Science ®Google Scholar
• Antonescu CR, Sung YS, Zhang L, Agaram NP, Fletcher CD. Recurrent srf-rela fusions define a novel subset of cellular myofibroma/myopericytoma: a potential diagnostic pitfall with sarcomas with myogenic differentiation. Am J Surg Pathol. 2017;41(5):677–84. doi:10.1097/PAS.0000000000000811.
   PubMed Web of Science ®Google Scholar
• Hung YP, Fletcher CDM. Myopericytomatosis: clinicopathologic analysis of 11 cases with molecular identification of recurrent pdgfrb alterations in myopericytomatosis and myopericytoma. Am J Surg Pathol. 2017;41(8):1034–44. doi:10.1097/PAS.0000000000000862.
   PubMed Web of Science ®Google Scholar
• Jiang X, Dai B, Feng L. Mir-543 promoted the cell proliferation and invasion of nasopharyngeal carcinoma by targeting the jam-a. Hum Cell. 2019;32(4):477–86. doi:10.1007/s13577-019-00274-0.
   PubMed Web of Science ®Google Scholar
• Agaram NP, Zhang L, Jungbluth AA, Dickson BC, Antonescu CR. A molecular reappraisal of glomus tumors and related pericytic neoplasms with emphasis on notch-gene fusions. Am J Surg Pathol. 2020;44(11):1556–62. doi:10.1097/PAS.0000000000001531.
   PubMed Web of Science ®Google Scholar
• Bemrich-Stolz CJ, Kelly DR, Muensterer OJ, Pressey JG. Single institution series of nodular fasciitis in children. J Pediatr Hematol Oncol. 2010;32(5):354–7. doi:10.1097/MPH.0b013e3181df6305.
   PubMed Web of Science ®Google Scholar
• Pandian TK, Zeidan MM, Ibrahim KA, Moir CR, Ishitani MB, Zarroug AE. Nodular fasciitis in the pediatric population: a single center experience. J Pediatr Surg. 2013;48(7):1486–9. doi:10.1016/j.jpedsurg.2012.12.041.
   PubMed Web of Science ®Google Scholar
• Chrisinger JSA JJ, Dehner LP. Soft tissue. In: Husain AN, Stocker J, Dehner LP, editors. Stocker and Dehner’s Pediatric Pathology. 5th ed. Philadelphia, PA: Wolters Kluwer; 2021. p. 1198–302.
   Google Scholar
• Patel NR, Chrisinger JSA, Demicco EG, Sarabia SF, Reuther J, Kumar E, Oliveira AM, Billings SD, Bovée JVMG, Roy A, et al. Usp6 activation in nodular fasciitis by promoter-swapping gene fusions. Mod Pathol. 2017;30(11):1577–88. doi:10.1038/modpathol.2017.78.
   PubMed Web of Science ®Google Scholar
• Erber R, Agaimy A. Misses and near misses in diagnosing nodular fasciitis and morphologically related reactive myofibroblastic proliferations: experience of a referral center with emphasis on frequency of usp6 gene rearrangements. Virchows Arch. 2018;473(3):351–60. doi:10.1007/s00428-018-2350-0.
   PubMed Web of Science ®Google Scholar
• Salib C, Edelman M, Lilly J, Fantasia JE, Yancoskie AE. Usp6 gene rearrangement by fish analysis in cranial fasciitis: a report of three cases. Head Neck Pathol. 2020;14(1):257–61. doi:10.1007/s12105-019-01018-0.
   PubMed Web of Science ®Google Scholar
• Paulson VA, Stojanov IA, Wasman JK, Restrepo T, Cano S, Plunkitt J, Duraisamy S, Harris MH, Chute DJ, Al-Ibraheemi A, et al. Recurrent and novel usp6 fusions in cranial fasciitis identified by targeted rna sequencing. Mod Pathol. 2020;33(5):775–80. doi:10.1038/s41379-019-0422-6.
   PubMed Web of Science ®Google Scholar
• Jebastin Thangaiah J, Vickery J, Selwanes W, Al-Haddad E, Perry KD, Palanisamy N, Poulik JM, Williamson SR, Chitale DA, Shehata BM, et al. A novel col1a1-camta1 rearrangement in cranial fasciitis. Int J Surg Pathol. 2020;28(6):678–82. doi:10.1177/1066896920912485.
   PubMed Web of Science ®Google Scholar
• Malik F, Wang L, Yu Z, Edelman MC, Miles L, Clay MR, Hedges D, Brennan RC, Nichols KE, Beth McCarville M, et al. Benign infiltrative myofibroblastic neoplasms of childhood with usp6 gene rearrangement. Histopathology. 2020;77(5):760–8. doi:10.1111/his.14182.
   PubMed Web of Science ®Google Scholar
• Pizem J, Matjasic A, Zupan A, Luzar B, Sekoranja D, Dimnik K. Fibroma of tendon sheath is defined by a usp6 gene fusion-morphologic and molecular reappraisal of the entity. Mod Pathol. 2021;34(10):1876–88. doi:10.1038/s41379-021-00836-4.
   PubMed Web of Science ®Google Scholar
• Terrier-Lacombe M-J, Guillou L, Maire G, Terrier P, Vince DR, de Saint Aubain Somerhausen N, Collin F, Pedeutour F, Coindre J-M. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data–a study from the french federation of cancer centers sarcoma group. Am J Surg Pathol. 2003;27(1):27–39. doi:10.1097/00000478-200301000-00004.
   PubMed Web of Science ®Google Scholar
• Thway K, Noujaim J, Jones RL, Fisher C. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies. Ann Diagn Pathol. 2016;25:64–71. doi:10.1016/j.anndiagpath.2016.09.013.
   PubMed Web of Science ®Google Scholar
• Gooskens SLM, Oranje AP, van Adrichem LNA, de Waard-van der Spek FB, den Hollander JC, van de Ven CP, van den Heuvel-Eibrink MM. Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP). Pediatr Blood Cancer. 2010;55(2):369–73. doi:10.1002/pbc.22494.
   PubMed Web of Science ®Google Scholar
• Han HH, Lim SY, Park YM, Rhie JW. Congenital dermatofibrosarcoma protuberans: a case report and literature review. Ann Dermatol. 2015;27(5):597–600. doi:10.5021/ad.2015.27.5.597.
   PubMed Web of Science ®Google Scholar
• Weinstein JM, Drolet BA, Esterly NB, Rogers M, Bauer BS, Wagner AM, Mancini AJ. Congenital dermatofibrosarcoma protuberans: variability in presentation. Arch Dermatol. 2003;139(2):207–11. doi:10.1001/archderm.139.2.207.
   PubMedGoogle Scholar
• Lee MS, Kang MJ, Kim MY, Kim HO, Song KY, Park YM. Congenital bednar tumour (pigmented dermatofibrosarcoma protuberans). J Eur Acad Dermatol Venereol. 2008;22(4):509–11. doi:10.1111/j.1468-3083.2007.02373.x.
   PubMed Web of Science ®Google Scholar
• Jha P, Moosavi C, Fanburg-Smith JC. Giant cell fibroblastoma: An update and addition of 86 new cases from the Armed Forces Institute of Pathology, in honor of Dr. Franz M. Enzinger. Ann Diagn Pathol. 2007;11(2):81–8. doi:10.1016/j.anndiagpath.2006.12.010.
   PubMed Web of Science ®Google Scholar
• Minoo P, Wang HY. Alk-immunoreactive neoplasms. Int J Clin Exp Pathol. 2012;5(5):397–410.
   PubMed Web of Science ®Google Scholar
• Dalton BGA, Thomas PG, Sharp NE, Manalang MA, Fisher JE, Moir CR, St Peter SD, Iqbal CW. Inflammatory myofibroblastic tumors in children. J Pediatr Surg. 2016;51(4):541–4. doi:10.1016/j.jpedsurg.2015.11.015.
   PubMed Web of Science ®Google Scholar
• Casanova M, Brennan B, Alaggio R, Kelsey A, Orbach D, van Noesel MM, Corradini N, Minard-Colin V, Zanetti I, Bisogno G, et al. Inflammatory myofibroblastic tumor: the experience of the European Pediatric Soft Tissue Sarcoma Study Group (epssg). Eur J Cancer. 2020;127:123–9. doi:10.1016/j.ejca.2019.12.021.
   PubMed Web of Science ®Google Scholar
• Lopez-Nunez O, John I, Panasiti RN, Ranganathan S, Santoro L, Grélaud D, Wu T, Buccoliero AM, Casanova M, Alaggio R, et al. Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases. Mod Pathol. 2020;33(4):576–90. doi:10.1038/s41379-019-0406-6.
   PubMed Web of Science ®Google Scholar
• Thirunavukkarasu B, Roy PS, Gupta K, Sekar A, Bansal D. Infantile inflammatory myofibroblastic tumor of spleen. Fetal Pediatr Pathol. 2020;23:1–5. doi:10.1080/15513815.2020.1836098.
   Google Scholar
• Lovly CM, Gupta A, Lipson D, Otto G, Brennan T, Chung CT, Borinstein SC, Ross JS, Stephens PJ, Miller VA, et al. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov. 2014;4(8):889–95. doi:10.1158/2159-8290.CD-14-0377.
   PubMed Web of Science ®Google Scholar
• Mossé YP, Voss SD, Lim MS, Rolland D, Minard CG, Fox E, Adamson P, Wilner K, Blaney SM, Weigel BJ, et al. Targeting alk with crizotinib in pediatric anaplastic large cell lymphoma and inflammatory myofibroblastic tumor: a children’s oncology group study. J Clin Oncol. 2017;35(28):3215–21. doi:10.1200/JCO.2017.73.4830.
   PubMed Web of Science ®Google Scholar
• Chang JC, Zhang L, Drilon AE, Chi P, Alaggio R, Borsu L, Benayed R, Travis WD, Ladanyi M, Antonescu CR, et al. Expanding the molecular characterization of thoracic inflammatory myofibroblastic tumors beyond alk gene rearrangements. J Thorac Oncol. 2019;14(5):825–34. doi:10.1016/j.jtho.2018.12.003.
   PubMed Web of Science ®Google Scholar
• Albert CM, Davis JL, Federman N, Casanova M, Laetsch TW. Trk fusion cancers in children: a clinical review and recommendations for screening. J Clin Oncol. 2019;37(6):513–24. doi:10.1200/JCO.18.00573.
   PubMed Web of Science ®Google Scholar
• Astolfi A, Fiore M, Melchionda F, Indio V, Bertuccio SN, Pession A. Bcor involvement in cancer. Epigenomics. 2019;11(7):835–55. doi:10.2217/epi-2018-0195.
   PubMed Web of Science ®Google Scholar
• Fetsch JF, Miettinen M, Laskin WB, Michal M, Enzinger FM. A clinicopathologic study of 45 pediatric soft tissue tumors with an admixture of adipose tissue and fibroblastic elements, and a proposal for classification as lipofibromatosis. Am J Surg Pathol. 2000;24(11):1491–500.
   PubMed Web of Science ®Google Scholar
• Malik F, Santiago T, Newman S, McCarville B, Pappo AS, Clay MR. An addition to the evolving spectrum of lipofibromatosis and lipofibromatosis-like neural tumor: molecular findings in an unusual phenotype aid in accurate classification. Pathol Res Pract. 2020;216(6):152942. doi:10.1016/j.prp.2020.152942.
   PubMed Web of Science ®Google Scholar
• Crumbach L, Descotes F, Bringuier P-P, Poulalhon N, Balme B, Juliet T, Lopez J, Harou O. Lipofibromatosis-like neural tumor: a case report and review of the literature. Am J Dermatopathol. 2020;42(11):881–4. doi:10.1097/DAD.0000000000001734.
   PubMed Web of Science ®Google Scholar
• Kao Y‐C, Suurmeijer AJH, Argani P, Dickson BC, Zhang L, Sung Y‐S, Agaram NP, Fletcher CDM, Antonescu CR. Soft tissue tumors characterized by a wide spectrum of kinase fusions share a lipofibromatosis-like neural tumor pattern. Genes Chromosomes Cancer. 2020;59(10):575–83. doi:10.1002/gcc.22877.
   PubMed Web of Science ®Google Scholar
• Al-Ibraheemi A, Folpe AL, Perez-Atayde AR, Perry K, Hofvander J, Arbajian E, Magnusson L, Nilsson J, Mertens F. Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases. Mod Pathol. 2019;32(3):423–34. doi:10.1038/s41379-018-0150-3.
   PubMed Web of Science ®Google Scholar
• Puls F, Hofvander J, Magnusson L, Nilsson J, Haywood E, Sumathi VP, Mangham DC, Kindblom L-G, Mertens F. Fn1-egf gene fusions are recurrent in calcifying aponeurotic fibroma. J Pathol. 2016;238(4):502–7. doi:10.1002/path.4683.
   PubMed Web of Science ®Google Scholar
• Saab ST, McClain CM, Coffin CM. Fibrous hamartoma of infancy: a clinicopathologic analysis of 60 cases. Am J Surg Pathol. 2014;38(3):394–401. doi:10.1097/PAS.0000000000000104.
   PubMed Web of Science ®Google Scholar
• Al-Ibraheemi A, Martinez A, Weiss SW, Kozakewich HP, Perez-Atayde AR, Tran H, Parham DM, Sukov WR, Fritchie KJ, Folpe AL, et al. Fibrous hamartoma of infancy: a clinicopathologic study of 145 cases, including 2 with sarcomatous features. Mod Pathol. 2017;30(4):474–85. doi:10.1038/modpathol.2016.215.
   PubMed Web of Science ®Google Scholar
• Martos-Cabrera L, Sampedro-Ruiz R, Perez-Gonzalez YC, Mentzel T, Llamas-Velasco M. Fibrous hamartoma of infancy: a series of 21 cases and review of the literature. Actas Dermosifiliogr. 2021;112(6):520–7. doi:10.1016/j.ad.2020.12.002.
   Web of Science ®Google Scholar
• Park JY, Cohen C, Lopez D, Ramos E, Wagenfuehr J, Rakheja D. EGFR exon 20 insertion/duplication mutations characterize fibrous hamartoma of infancy. Am J Surg Pathol. 2016;40(12):1713–8. doi:10.1097/PAS.0000000000000729.
   PubMed Web of Science ®Google Scholar
• Ellington N, Park JY, King K, Josephs S, Rakheja D. EGFR exon 20 insertion/duplication mutation in fibrous hamartoma of infancy with predominantly pseudoangiomatous pattern mimicking giant cell fibroblastoma. Int J Surg Pathol. 2017;25(5):421–4. doi:10.1177/1066896917698569.
   PubMed Web of Science ®Google Scholar
• Leclerc S, Hamel-Teillac D, Oger P, Brousse N, Fraitag S. Plexiform fibrohistiocytic tumor: three unusual cases occurring in infancy. J Cutan Pathol. 2005;32(8):572–6. doi:10.1111/j.0303-6987.2005.00334.x.
   PubMed Web of Science ®Google Scholar
• Galeotti N, Quattrone A, Vivoli E, Bartolini A, Ghelardini C. Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. Neuroscience. 2007;149(2):409–20. doi:10.1016/j.neuroscience.2007.07.049.
   PubMed Web of Science ®Google Scholar
• Muezzinoglu B, Tohumcu A, Ekingen G. An unusual occurence of plexiform fibrohistiocytic tumour: congenital tumour diagnosed at 7 years of age. Pathology. 2011;43(4):380–1. doi:10.1097/PAT.0b013e328346872b.
   PubMed Web of Science ®Google Scholar
• Sandrini J, Michalak S, Croue A, Hubault P, Rousselet MC. [A rare cutaneous congenital sarcoma: plexiform fibrohistiocytic tumor]. Ann Pathol. 2011;31(3):222–5. doi:10.1016/j.annpat.2011.02.011.
   PubMed Web of Science ®Google Scholar
• Hornick JL, Fletcher CD. Cellular neurothekeoma: detailed characterization in a series of 133 cases. Am J Surg Pathol. 2007;31(3):329–40. doi:10.1097/01.pas.0000213360.03133.89.
   PubMed Web of Science ®Google Scholar
• Allemant Ortiz LJ, Calderon-Castrat X, Orellana Cortez A, Ingar Carbone B, Santos-Briz A. Congenital atrophic plaque: fibroblastic connective tissue nevus. Pediatr Dermatol. 2017;34(4):e216–8. doi:10.1111/pde.13155.
   PubMed Web of Science ®Google Scholar
• Lynch MC, Samson TD, Zaenglein AL, Chung CG. Evolution of fibroblastic connective tissue nevus in an infant. Am J Dermatopathol. 2017;39(3):225–7. doi:10.1097/DAD.0000000000000726.
   PubMed Web of Science ®Google Scholar
• Bouaoud J, Fraitag S, Soupre V, Mitrofanoff M, Boccara O, Galliot C, Bodemer C, Picard A, Khonsari RH. Congenital fibroblastic connective tissue nevi: unusual and misleading presentations in three infantile cases. Pediatr Dermatol. 2018;35(5):644–50. doi:10.1111/pde.13571.
   PubMed Web of Science ®Google Scholar
• de Feraudy S, Fletcher CD. Fibroblastic connective tissue nevus: a rare cutaneous lesion analyzed in a series of 25 cases. Am J Surg Pathol. 2012;36(10):1509–15. doi:10.1097/PAS.0b013e31825e63bf.
   PubMed Web of Science ®Google Scholar
• Horikawa H, Sato T, Gomi H, Yamazaki K, Ishida Y, Yuzaki I, Fukuzumi S. Medallion-like dermal dendrocyte hamartoma: a rare congenital cd34-positive dermal lesion clinically and pathologically overlapping with fibroblastic connective tissue nevus. Pediatr Dermatol. 2019;36(3):397–9. doi:10.1111/pde.13766.
   PubMed Web of Science ®Google Scholar
• Köse D, Annagür A, Erol C, Uğraş S, Köksal Y. Synovial sarcoma in a premature newborn. Pediatr Int. 2014;56(3):e17–20. doi:10.1111/ped.12338.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan V, Joel A, Sundersingh S, Raja A. Synovial sarcoma in a neonate. Indian Pediatr. 2016;53(4):345–6. doi:10.1007/s13312-016-0850-z.
   PubMed Web of Science ®Google Scholar
• Kirino T, Funakoshi Y, Miyata N, Okada M, Moriuchi H. Synovial sarcoma of the left forearm in a neonate. Pediatr Int. 2018;60(6):604–5. doi:10.1111/ped.13581.
   PubMed Web of Science ®Google Scholar
• Leiner J, Le Loarer F. The current landscape of rhabdomyosarcomas: an update. Virchows Arch. 2020;476(1):97–108. doi:10.1007/s00428-019-02676-9.
   PubMed Web of Science ®Google Scholar
• Chen S, Rudzinski ER, Arnold MA. Challenges in the diagnosis of pediatric spindle cell/sclerosing rhabdomyosarcoma. Surg Pathol Clin. 2020;13(4):729–38. doi:10.1016/j.path.2020.08.010.
   PubMedGoogle Scholar
• Whittle SB, Hicks MJ, Roy A, Vasudevan SA, Reddy K, Venkatramani R. Congenital spindle cell rhabdomyosarcoma. Pediatr Blood Cancer. 2019;66(11):e27935. doi:10.1002/pbc.27935.
   PubMed Web of Science ®Google Scholar
• Alaggio R, Zhang L, Sung Y-S, Huang S-C, Chen C-L, Bisogno G, Zin A, Agaram NP, LaQuaglia MP, Wexler LH, et al. A molecular study of pediatric spindle and sclerosing rhabdomyosarcoma: identification of novel and recurrent vgll2-related fusions in infantile cases. Am J Surg Pathol. 2016;40(2):224–35. doi:10.1097/PAS.0000000000000538.
   PubMed Web of Science ®Google Scholar
• Tan GZL, Saminathan SN, Chang KTE, Odoño EG, Kuick CH, Chen H, Lee VKM. A rare case of congenital spindle cell rhabdomyosarcoma with tead1-ncoa2 fusion: a subset of spindle cell rhabdomyosarcoma with indolent behavior. Pathol Int. 2020;70(4):234–6. doi:10.1111/pin.12908.
   PubMed Web of Science ®Google Scholar
• Agaram NP, LaQuaglia MP, Alaggio R, Zhang L, Fujisawa Y, Ladanyi M, Wexler LH, Antonescu CR. Myod1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification. Mod Pathol. 2019;32(1):27–36. doi:10.1038/s41379-018-0120-9.
   PubMed Web of Science ®Google Scholar
• Coffin CM, Dehner LP. Soft tissue tumors in first year of life: a report of 190 cases. Pediatr Pathol. 1990;10(4):509–26. doi:10.3109/15513819009067140.
   PubMedGoogle Scholar
• Miettinen M, Felisiak-Golabek A, Luiña Contreras A, Glod J, Kaplan RN, Killian JK, Lasota J. New fusion sarcomas: histopathology and clinical significance of selected entities. Hum Pathol. 2019;86:57–65. doi:10.1016/j.humpath.2018.12.006.
   PubMed Web of Science ®Google Scholar
• Vokuhl C, Nourkami-Tutdibi N, Furtwangler R, Gessler M, Graf N, Leuschner I. Etv6-ntrk3 in congenital mesoblastic nephroma: a report of the siop/gpoh nephroblastoma study. Pediatr Blood Cancer. 2018;65(4):e26925. doi:10.1002/pbc.26925.
   Web of Science ®Google Scholar
• Gatalica Z, Xiu J, Swensen J, Vranic S. Molecular characterization of cancers with ntrk gene fusions. Mod Pathol. 2019;32(1):147–53. doi:10.1038/s41379-018-0118-3.
   PubMed Web of Science ®Google Scholar
• Mito JK, Bishop JA, Sadow PM, Stelow EB, Faquin WC, Mills SE, Krane JF, French CA, Fletcher CDM, Hornick JL, et al. Immunohistochemical detection and molecular characterization of idh-mutant sinonasal undifferentiated carcinomas. Am J Surg Pathol. 2018;42(8):1067–75. doi:10.1097/PAS.0000000000001064.
   PubMed Web of Science ®Google Scholar
• Hung YP, Fletcher CDM, Hornick JL. Evaluation of pan-trk immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics. Histopathology. 2018;73(4):634–44. doi:10.1111/his.13666.
   PubMed Web of Science ®Google Scholar
• Brčić I, Godschachner TM, Bergovec M, Igrec J, Till H, Lackner H, Scheipl S, Kashofer K, Brodowicz T, Leithner A, et al. Broadening the spectrum of ntrk rearranged mesenchymal tumors and usefulness of pan-trk immunohistochemistry for identification of ntrk fusions. Mod Pathol. 2021;34(2):396–407. doi:10.1038/s41379-020-00657-x.
   PubMed Web of Science ®Google Scholar
• Haller F, Knopf J, Ackermann A, Bieg M, Kleinheinz K, Schlesner M, Moskalev EA, Will R, Satir AA, Abdelmagid IE, et al. Paediatric and adult soft tissue sarcomas with ntrk1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern. J Pathol. 2016;238(5):700–10. doi:10.1002/path.4701.
   PubMed Web of Science ®Google Scholar
• Sirvent N, Maire G, Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer. 2003;37(1):1–19. doi:10.1002/gcc.10202.
   PubMed Web of Science ®Google Scholar
• Hiemcke-Jiwa LS, van Gorp JM, Fisher C, Creytens D, van Diest PJ, Flucke U. Usp6-associated neoplasms: a rapidly expanding family of lesions. Int J Surg Pathol. 2020;28(8):816–25. doi:10.1177/1066896920938878.
   PubMed Web of Science ®Google Scholar
• Giannikopoulos P, Parham DM. Rhabdomyosarcoma: how advanced molecular methods are shaping the diagnostic and therapeutic paradigm. Pediatr Dev Pathol. 2021;24(5):395–404. doi:10.1177/10935266211013621.
   PubMed Web of Science ®Google Scholar